Pharmaceutical composition of a potent HCV inhibitor for oral administration

Details for Australian Patent Application No. 2009316755 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Chen, Feng-Jing; Gel, Juan Francisco; Villagra, Maria Fernanda

Agent Spruson & Ferguson

Pub. Number AU-A-2009316755

PCT Pub. Number WO2010/059667

Priority 61/116,789 21.11.08 US

Filing date 18 November 2009

Wipo publication date 27 May 2010

International Classifications

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61K 9/10 (2006.01) Medicinal preparations characterised by special physical form - Dispersions

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61K 47/14 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Esters of carboxylic acids

Event Publications

28 April 2011 PCT application entered the National Phase

  PCT publication WO2010/059667 Priority application(s): WO2010/059667

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009316756-A triazolothiadiazole inhibitor of c-Met protein kinase

2009316749-Methods of determining polydispersity and/or molecular weight distribution of a polyethylene glycol sample